Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Intuitive Surgical
ISRG
|
+$875M |
| 3 |
Amazon
AMZN
|
+$816M |
| 4 |
Intercontinental Exchange
ICE
|
+$721M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$661M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.3B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$971M |
| 3 |
Apple
AAPL
|
+$593M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$419M |
| 5 |
Shopify
SHOP
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.02% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.26% |
| 4 | Communication Services | 8.33% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
4826
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $250K | ﹤0.01% |
25,449
-1,601
| -6% | -$15.8K |
|
|
CFRX
4827
DELISTED
ContraFect Corporation
CFRX
| $250K | ﹤0.01% |
591
-82
| -12% | -$37.2K |
|
4828
Horizon Bancorp
HBNC
$1.06B
| $249K | ﹤0.01% |
24,702
-22,190
| -47% | -$230K |
|
4829
Mustang Bio
MBIO
$4.37M
| $249K | ﹤0.01% |
105
+7
| +7% | +$17.3K |
|
4830
Spyre Therapeutics
SYRE
$8.24B
| $249K | ﹤0.01% |
1,404
+385
| +38% | +$71.2K |
|
|
CEA
4831
DELISTED
China Eastern Airlines
CEA
| $249K | ﹤0.01% |
11,520
+11,487
| +34,809% | +$228K |
|
4832
Marathon Digital Holdings
MARA
$4.48B
| $248K | ﹤0.01% |
126,729
+126,691
| +333,397% | +$272K |
|
4833
Zentalis Pharmaceuticals
ZNTL
$331M
| $248K | ﹤0.01% |
7,574
-2,551
| -25% | -$89.3K |
|
|
ECOM
4834
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $248K | ﹤0.01% |
17,125
-13,199
| -44% | -$219K |
|
|
WTRE
4835
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $248K | ﹤0.01% |
10,781
-38,717
| -78% | -$708K |
|
4836
Liquidia Corp
LQDA
$7.46B
| $247K | ﹤0.01% |
50,174
+34,779
| +226% | +$201K |
|
|
MRCC
4837
DELISTED
Monroe Capital Corp
MRCC
| $246K | ﹤0.01% |
35,947
-11,247
| -24% | -$76.9K |
|
|
ATXI
4838
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $246K | ﹤0.01% |
20
+15
| +300% | +$182K |
|
|
MCBC
4839
DELISTED
Macatawa Bank Corp
MCBC
| $246K | ﹤0.01% |
37,635
+2,394
| +7% | +$17.3K |
|
4840
PMV Pharmaceuticals
PMVP
$59.7M
| $245K | ﹤0.01% |
+6,900
| New | +$254K |
|
4841
CorMedix
CRMD
$592M
| $244K | ﹤0.01% |
40,380
+29,248
| +263% | +$147K |
|
|
SCPH
4842
DELISTED
scPharmaceuticals
SCPH
| $244K | ﹤0.01% |
32,703
-5,606
| -15% | -$43.8K |
|
|
ESSA
4843
DELISTED
ESSA Bancorp
ESSA
| $243K | ﹤0.01% |
19,657
-2,567
| -12% | -$33.5K |
|
4844
McEwen Inc
MUX
$1.07B
| $243K | ﹤0.01% |
23,015
+2,577
| +13% | +$31.2K |
|
|
SNCR
4845
DELISTED
Synchronoss Technologies
SNCR
| $243K | ﹤0.01% |
8,987
+6,348
| +241% | +$210K |
|
|
OTIC
4846
DELISTED
Otonomy, Inc.
OTIC
| $243K | ﹤0.01% |
59,852
+23,801
| +66% | +$89.7K |
|
4847
Lands' End
LE
$382M
| $242K | ﹤0.01% |
18,602
+2,858
| +18% | +$32.1K |
|
|
USAS
4848
Americas Gold and Silver
USAS
$1.38B
| $242K | ﹤0.01% |
36,652
+6,360
| +21% | +$47K |
|
4849
First Western Financial
MYFW
$312M
| $241K | ﹤0.01% |
18,589
-1,248
| -6% | -$17.1K |
|
4850
Euro Tech Holdings
CLWT
$11M
| $240K | ﹤0.01% |
225,020
+50,927
| +29% | +$57.3K |
|
Similar funds
Morgan Stanley's Q3 2020 Portfolio in Review
As of Q3 2020, Morgan Stanley held 7,017 positions worth $517B, up 14% from $452B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley deployed $20.1B of net new capital in Q3 2020, opening 295 new positions and adding to 2,843 existing holdings. Its largest new stake was Snowflake: 1,409,359 shares worth $354M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.
- Morgan Stanley's largest Q3 2020 buy was Snowflake: 1,409,359 shares worth $354M.
- Morgan Stanley added most to Invesco QQQ Trust in Q3 2020, an estimated $1.09B increase.
- Morgan Stanley's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
- Morgan Stanley fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $90.7M.
- Morgan Stanley's ten largest holdings make up 17% of its $517B portfolio in Q3 2020.
- Morgan Stanley opened 295 new positions and closed 175 in Q3 2020.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $517B.
Based on Morgan Stanley's 13F filing for Q3 2020, filed 13 Nov 2020.